Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies using immuno-DASH inhibitors and PGE2 antagonists

Combination therapies using immuno-DASH inhibitors and PGE2 antagonists

US Patent 12478609 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FAP-activated proteasome inhibitors for treating solid tumors2025
FAP-activated proteasome inhibitors for treating solid tumors2025
Fap-activated therapeutic agents, and uses related thereto2024
Fap-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024
Combination therapies using immuno-dash inhibitors and PGE2 antagonists2024
Combination therapies using immuno-dash inhibitors and PGE2 antagonists2024
FAP-activated therapeutic agents, and uses related thereto2024
FAP-activated therapeutic agents, and uses related thereto2024